Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a radical method of chronic myeloid leukemia (CML) treatment. In the 1990s CML became the most frequent indication for allo-HSCT worldwide. CML treatment drastically changed after tyrosine kinase inhibitors (TKI) had been introduced i...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2019-03-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: |
http://bloodjournal.ru/wp-content/uploads/2020/03/10.pdf
|